Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »
2/347 von 416    DIMDI: MEDLINE (ME60) © NLM
ND: ME09824843
PMID: 9824843
LR: 20041117
CED: 19990217
DCO: 19990217
Autoren: Russell AL
Titel: Glucosamine in osteoarthritis and gastrointestinal disorders: an exemplar of the need for a paradigm shift.
Quelle: Medical hypotheses; VOL: 51 (4); p. 347-9 /199810/
PM: Print
SU: IM
Sprache: English
CY: ENGLAND
JID: 7505668
ISSN: 0306-9877
CO: MEHYDY
Institution: Brampton Pain Clinic, Bramalea, Ontario, Canada.
DT: Journal Article
Schlagwörter
CT: ANIMALS; GLUCOSAMINE/pharmacology; GLUCOSAMINE/*therapeutic use; HUMANS; INFLAMMATORY BOWEL DISEASES/drug therapy; INFLAMMATORY BOWEL DISEASES/etiology; OSTEOARTHRITIS/*drug therapy; OSTEOARTHRITIS/etiology; WOUND HEALING/drug effects
CTG: TIER; GLUCOSAMIN/Pharmakologie; GLUCOSAMIN/*therapeutische Anwendung; MENSCH; ENTZÜNDLICHE DARMKRANKHEITEN/Arzneimitteltherapie; ENTZÜNDLICHE DARMKRANKHEITEN/Ätiologie; OSTEOARTHROSE/*Arzneimitteltherapie; OSTEOARTHROSE/Ätiologie; WUNDHEILUNG/Arzneimittelwirkungen
TE: Glucosamine/3416-24-8
CR: 3416-24-8
AB: Glucosamine, after a latent period, is rapidly developing a position in the treatment of osteoarthritis, as well as a potential therapeutic place in wound healing and gastrointestinal disorders. Although recognized for a great many years, the association of gastrointestinal disorders and arthritis has been looked on as an unexplained oddity. Could this be indicative of a common etiology in the rate-limiting production of glucosamine? Could diverse presentations and pathology be due to a common-stem biochemical defect?
» Volltext »

» Fenster schließen »